OBJECTIVES: To compare our modified retroperitoneoscopic adrenalectomy with the standard procedure. METHODS: A total of 68 @entity1 underwent modified retroperitoneoscopic adrenalectomy. Simultaneously, another 23 @entity1 were treated using the standard procedure. The demographic data and perioperative outcomes of the @entity1 were obtained for statistical analysis. RESULTS: No significant differences in age, evaluated @entity190 , @entity1697 , and hospital stay were observed. The mean operation time in the modified group was shorter than that in the standard group (58.3  16.4 vs. 79.5  23.6 min, P<0.05). The median total length of incision was shorter in the modified group than in the standard group (4.5  0.8 vs. 6.4  1.1 cm, P<0.05). The modified group also showed significantly @entity158 control (3 vs. 6 @entity3522 use, P<0.05) and cosmetic outcome (score, 9.1  1.8 vs. 8.2  2.1, P<0.05) than the standard group. CONCLUSIONS: Our modified retroperitoneoscopic adrenalectomy is a safe and alternative procedure for @entity5 . This procedure offers superior cosmetic outcome, @entity158 control, and shorter operation time compared with the standard retroperitoneal adrenalectomy.

Comparison of Modified Retroperitoneal Adrenalectomy With the Gold Standard for Benign XXXX .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity1697 :: ('MESH:D009062', 'Disease') :: ['oral intake'] @entity3522 :: ('MESH:D004008', 'Chemical') :: ['diclofenac sodium'] @entity190 :: ('MESH:D006473', 'Disease') :: ['blood loss'] @entity5 :: ('MESH:D009369', 'Disease') :: ['adrenal tumors'] @entity158 :: ('MESH:D010146', 'Disease') :: ['better pain']
@entity5 :: (MESH:D009369,Disease) :: ['Adrenal Tumors']
